Hepatocellular Carcinoma
Conditions
Interventions
test team:TACE+ Chinese medicine granule
control group:TACE+placebo
Sponsors
Beijing Hospital of TCM
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. With the western medicine, Chinese medicine diagnosis of primary hepatocellular carcinoma; 2. Meet the indications for TACE; 3. Stage II or III; 4. Unable or unwilling to accept surgical treatment or surgical treatment of incomplete or recurrence; Using Child-Pugh improved liver function classification, liver function rating of A or B; 5. The liver function was improved by Child-Pugh classification method, and the liver function was rated as A or B. 6.According to the The guiding principle of clinical research on new drugs" determinant for liver stagnation and spleen deficiency; 7. Aged 18-75; 8. The function of the important organs such as heart and kidney is normal; 9. The ECOG score of 0-2, the expected survival time more than 3 months; 10.Preoperative patients based on image science data measured tumor size. If the lesion was solitary and maximum tumor diameter greater than or equal to 5 cm; if multiple lesions, multiple maximum lesion diameter and greater than or equal to 5cm. 11. Signed informed consent, voluntary subjects.
Exclusion criteria
Exclusion criteria: 1. Metastatic liver cancer; 2. Bile duct carcinoma with clear pathological diagnosis; 3. Having TACE treatment contraindications; 4. Having similar symptoms like PES before TACE; 5. With serious heart, kidney and hematopoietic system of primary disease or mental disorder or having serious complications such as liver failure, upper gastrointestinal bleeding in prior TACE; 6.gestation or lactating; 7. participating other clinical drug experimental group;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| symptom;liver function; | — |
Secondary
| Measure | Time frame |
|---|---|
| TCM syndrome integral;Physical fitness evaluation; | — |
Countries
China
Contacts
Public ContactGuowang Yang
Outcome results
None listed